LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
1-Year Return
5.19%
This Quarter Return
-1.97%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$2.43B
AUM Growth
+$435M
(+22%)
Cap. Flow
+$677M
Cap. Flow
% of AUM
27.9%
Top 10 Holdings %
Top 10 Hldgs %
39.01%
Holding
975
New
377
Increased
84
Reduced
94
Closed
348
Top Buys
| 1 |
AABA
Altaba Inc. Common Stock
AABA
|
$145M |
| 2 |
CELG
Celgene Corp
CELG
|
$123M |
| 3 |
Amazon
AMZN
|
$100M |
| 4 |
Adobe
ADBE
|
$99.8M |
| 5 |
Netflix
NFLX
|
$92.8M |
Top Sells
| 1 |
Merck
MRK
|
$93.7M |
| 2 |
Union Pacific
UNP
|
$73.4M |
| 3 |
LyondellBasell Industries
LYB
|
$47.4M |
| 4 |
Elanco Animal Health
ELAN
|
$46.3M |
| 5 |
Boston Scientific
BSX
|
$41.7M |
Sector Composition
| 1 | Technology | 26.42% |
| 2 | Healthcare | 18.01% |
| 3 | Communication Services | 13.28% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 6.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Castle Biosciences
CSTL
$683M
| $542K | ﹤0.01% |
+29,986
| New | +$542K |
|
377
Ormat Technologies
ORA
$5.51B
| $542K | ﹤0.01% |
+7,300
| New | +$542K |
|
378
LCI Industries
LCII
$2.57B
| $541K | ﹤0.01% |
+5,894
| New | +$541K |
|
379
SS&C Technologies
SSNC
$21.7B
| $534K | ﹤0.01% |
+10,350
| New | +$534K |
|
380
Take-Two Interactive
TTWO
$44.2B
| $525K | ﹤0.01% |
4,185
-1,500
| -26% | -$188K |
|
381
Whirlpool
WHR
$5.28B
| $523K | ﹤0.01% |
+3,300
| New | +$523K |
|
382
Moderna
MRNA
$9.78B
| $522K | ﹤0.01% |
32,819
-99,600
| -75% | -$1.58M |
|
383
Booking.com
BKNG
$178B
| $520K | ﹤0.01% |
+265
| New | +$520K |
|
384
Acadia Realty Trust
AKR
$2.63B
| $519K | ﹤0.01% |
+18,147
| New | +$519K |
|
|
SEMG
385
DELISTED
SEMGROUP CORPORATION
SEMG
| $515K | ﹤0.01% |
+31,500
| New | +$515K |
|
386
Devon Energy
DVN
$22.1B
| $514K | ﹤0.01% |
21,382
+20,382
| +2,038% | +$490K |
|
|
HNGR
387
DELISTED
Hanger Inc.
HNGR
| $513K | ﹤0.01% |
+25,172
| New | +$513K |
|
388
Federal Signal
FSS
$7.59B
| $501K | ﹤0.01% |
15,300
+2,207
| +17% | +$72.3K |
|
389
UFP Industries
UFPI
$6.08B
| $501K | ﹤0.01% |
+12,556
| New | +$501K |
|
390
Gannett
GCI
$629M
| $493K | ﹤0.01% |
+55,915
| New | +$493K |
|
391
Healthcare Services Group
HCSG
$1.15B
| $490K | ﹤0.01% |
+20,162
| New | +$490K |
|
392
Palo Alto Networks
PANW
$130B
| $489K | ﹤0.01% |
14,400
+8,400
| +140% | +$285K |
|
|
MDLA
393
DELISTED
Medallia, Inc.
MDLA
| $480K | ﹤0.01% |
+17,500
| New | +$480K |
|
394
Parsons
PSN
$8.08B
| $474K | ﹤0.01% |
14,364
-186,936
| -93% | -$6.17M |
|
395
Global Net Lease
GNL
$1.77B
| $468K | ﹤0.01% |
+24,002
| New | +$468K |
|
396
Exagen
XGN
$213M
| $465K | ﹤0.01% |
+30,000
| New | +$465K |
|
397
Heron Therapeutics
HRTX
$201M
| $456K | ﹤0.01% |
+24,624
| New | +$456K |
|
398
Vanda Pharmaceuticals
VNDA
$272M
| $453K | ﹤0.01% |
34,100
+7,145
| +27% | +$94.9K |
|
399
Vertex Pharmaceuticals
VRTX
$102B
| $453K | ﹤0.01% |
+2,675
| New | +$453K |
|
400
Zoetis
ZTS
$67.9B
| $450K | ﹤0.01% |
+3,615
| New | +$450K |
|